Evidence map›Paper›PMID 32710175›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2020

A high number of multidrug-resistant and predominant genetically related cluster of Shigella flexneri strains isolated over 34 years in Brazil.

Júlia Cunha Gonzales, Amanda Aparecida Seribelli, Carolina Nogueira Gomes, Dália Dos Prazeres Rodrigues, Fábio Campioni, Jaqueline Passaglia, Paulo da Silva, Juliana Pfrimer Falcão

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. High pathogenic potential of Shigella flexneri strains descending from a common ancestor isolated over 34 years in Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Júlia Cunha GonzalesDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil.
Amanda Aparecida SeribelliDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil.
Carolina Nogueira GomesDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil.
Dália Dos Prazeres RodriguesFundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Fábio CampioniDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil.
Jaqueline PassagliaDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil.
Paulo da SilvaInstituto Adolfo Lutz de Ribeirão Preto, São Paulo, Brazil.
Juliana Pfrimer FalcãoDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo-USP, Av. do Café, s/no-Campus Universitário USP, Ribeirão Preto, SP, 14040-903, Brazil. jufalcao@fcfrp.usp.br.ORCID http://orcid.org/0000-0002-1459-9355

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 303475/2015-3 and 304399/2018-3Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/ 13029-0 and 2016/2716-3
6 · The paper itself

Abstract

Shigella flexneri has been a major public health problem in developing countries. This work analyzed the frequency of 16 virulence genes, the genotypic diversity, and the antimicrobial resistance profiles of 130 S. flexneri strains isolated in Brazil. The ipaH gene was found in all the 130 strains. The frequencies of the other genes were variable ial (88.5%), sigA (82.3%), iuc (74.6%), virA (73%), pic (72.3%), virF (57.7%), sat (48.5%), ipaBCD (37%), sen (36%), set1A (35.4%), sepA (30%), set1B (30%), virB (14%), icsA (10%), and ipgD (5.4%). A total of 57 (43.8%) strains were multidrug-resistant. ERIC-PCR grouped 96 of the strains into a single cluster with ≥ 70.4% of similarity, 75 of these strains presented a similarity ≥ 80.9%. PFGE grouped 120 of the strains into a single cluster with 57.4% of similarity and 82 of these strains presented a similarity ≥ 70.6%. In conclusion, the high frequency of some virulence genes reinforces the pathogenic potential of the strains studied. The high rates of MDR strains are alarming once it may lead to failure when antimicrobial treatment is necessary. Genotype techniques reveled a major cluster with high genetic similarity including S. flexneri strains from the different Brazilian states and distinct years of isolation, showing that they probably emerged from a common ancestor.

Indexed as

Shigella flexneriBrazilDrug Resistance, Multiple, BacterialDysentery, BacillaryGenetic VariationHumansVirulence FactorsVirulence FactorsAntimicrobial resistanceERIC-PCRPFGEShigella flexneriVirulence genes

Identifiers

PMID32710175
PMCPMC7688809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.